Search

everythinglearnresearchcommunity

for

Search:↓

Treating vitiligo with stem cells and melanocytes from hair, along with UVB light, works better than without the light.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Panitumumab can cause excessive ear hair growth.

Platelet-rich plasma may improve vitiligo treatment when used with phototherapy.

Upadacitinib may effectively treat resistant lichen planopilaris.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Verteporfin reduces growth and stem cell traits in rat hair follicle cells by blocking the Hippo pathway.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

The protein p21 is more abundant in normal skin cells than in melanoma cells and may help protect against melanoma, with UVB light affecting its levels.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Cannabidivarin (CBDV) may help brain cell growth and survival through the TRPV1 receptor.

Nilotinib can cause generalized keratosis pilaris.

Tangent screens help detect visual field defects from vigabatrin.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.